In 2020, SONIRE was founded and began developing a next-generation ultrasound-guided high-intensity focused ultrasound (HIFU) therapy system using the technology, clinical know-how, and regulatory science experience built over a decade at Tokyo Women’s Medical University, Tohoku University, and Tokyo Medical University. SONIRE is conducting a multicenter, randomized controlled clinical trial for unresectable pancreatic cancer in Japan.
BIO DOUBLE HELIX SPONSORS
BIO HELIX SPONSORS
